Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 4, 1996, Pages 887-893

  Rietbroek, Ron C ^a,b   Bakker, Piet J M ^a   Schilthuis, Marten S ^a   Postma, Arjan J ^a   Zum Vörde Sive Vörding, Paul J ^a   Gonzalèz Gonzalèz, Dionisio ^a   Kurth, Karl Heinz ^a   Bakker, Ad J ^a   Veenhof, Cees H N ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Cervical carcinoma; Cisplatin; Hyperthermia induced; Toxicity

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD TOXICITY; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG POTENTIATION; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIC THERAPY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0029986862     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02152-3     Document Type: Article

References (40)

1. Alberts, D. S.; Garcia, D.; Mason-Lidill, N. Cisplatin in advanced cancer of the cervix: An update. Semin. Oncol. 18(1)(Suppl. 3):11-24; 1991.
2. Cockroft, D. W.; Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41; 1976.
3. Dahl, O.; Mella, O. Hyperthermia and chemotherapeutic agents. In: Field, S. B.; Hand, J. W., eds. An introduction to the practical aspects of clinical hyperthermia. London: Taylor and Francis 1990:108-133.
4. Dahl, O.; Mella, O.; Mekus, A.; Liavang, P. G. Clinical hyperthermia combined with drug and radiation. A phase I/II study. Strahlenther. Onkol. 163:446-448; 1987.
5. Dijk van, J. D. P.; Schneider, C.; Os van, R.; Blank, L. E. C. M.; Gonzalez Gonzalez, D. Results of deep body hyperthermia with large waveguide radiators. In: Bicher, H. I., ed. Consensus on hyperthermia for the 1990s. New York: Plenum Press; 1990:315-319.
6. Emami, B.; Myerson, R. J.; Scott, C.; Gibbs, F.; Lee, C.; Perez, C. A. A phase I/II study combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: Report of a pilot study by the radiation therapy oncology group. Int. J. Radiat. Oncol. Biol. Phys. 20:73-79; 1991.
7. Gerad, H.; Egorin, M. J.; Whitacre, M.; Van Echo, D. A.; Aisner, J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole body hyperthermia. Cancer Chemother. Pharmacol. 11(3):162-166; 1983.
8. Green, D. M.; Burton, G. V.; Cox, E. B.; Hanson, D.; Moore, J.; Oleson, J. R. A phase I/II study of combined cisplatin and hyperthermia for refractory malignancy. Int. J. Hyperthermia 5(1):13-21; 1989.
9. Hahn, G. M.; Li, G. C. Interaction of hyperthermia and drugs: Treatments and probes. Natl. Cancer Inst. Monogr. 61:317; 1982.
10. Herman, T. S.; Jochelson, M. S.; Teicher, B. A.; Scott, P. J.; Hansen, J.; Clark, J. R.; Pfeffer, R.; Gelwan, L. E.; Molnar-Griffin, B. J.; Fraser, S. M.; Svensson, G.; Bornstein, B. A.; Coleman, C. N. A phase I/II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int. J. Radiat. Oncol. Biol. Phys. 17:1273-1279; 1989.
11. 2(tetrachloroplatinum(II)) in a human squamous cell carcinoma line and a cisdiamminedichloroplatinum (II)-resistant subline. Cancer Res. 48:5101-5105; 1988.
12. Hillcoat, B. L.; Raghavan, D.; Matthews, J.; Kefford, R.; Yuen, K.; Woods, R.; Olver, I.; Bishop, J.; Pearson, B.; Coorey, G.; Levi, J.; Abott, R. C.; Aroney, R.; Gill, P. G.; McLennan, R. A randomized trial of cisplatin vs. cisplatin plus methotrexate in advanced cancer of the urothelial tract. J. Clin. Oncol. 7:706-709; 1989.
13. Hoogeveen, J. F.; van der Kracht, A. H. W.; Wondergem, J.; Gonzalez Gonzalez, D.; Haveman, J. Influence of cisplatin on the sensitivity of the rat sciatic nerve to local hyperthermia. Neurotoxicology 14(1):1-8; 1993.
14. Issels, R. D.; Mittermüller, J.; Gerl, A.; Simon, W.; Ortmaier, A.; Denzlinger, C.; Sauer, H.; Willmanns, W. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: Updated report on 65 patients. J. Cancer Res. Clin. Oncol. 117(Suppl. 4):141-147; 1991.
15. Issels, R. D.; Wadepohl, M.; Tilling, K.; Muller, M.; Sauer, H.; Willmanns, W. Regional hyperthermia combined with systemic chemotherapy in advanced abdominal and pelvic tumors; First results of a pilot study employing an annular phased array applicator. Recent Results Cancer Res. 107:236-243; 1988.
16. Kaern, J.; Trope, C.; Abeler, V.; Iversen, T.; Kjorstad, K. A phase II study of 5-fluorouracil/cisplatinum in recurrent cervical cancer. Acta Oncol. 29(1):25-28; 1990.
17. Konings, A. W. T.; Hettinga, J. V. E.; Lemstra, W.; Humphrey, G. B.; Kampinga, H. H. Sensitizing for cis-diamminedichloroplatinum(II) action by hyperthermia in resistant cells. Int. J. Hyperthermia 9:553-562; 1993.
18. Lele, S. B.; Piver, M. S. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma. Gynecol. Oncol. 33(1):6-8; 1989.
19. Loehrer, P. J.; Einhorn, L. H.; Elson, P. J.; Crawford, P.; Kuebler, P.; Tannock, I.; Raghaven, D.; Stuart-Harris, R.; Sarosdy, M. F.; Lowe, B. A.; Blumenstein, B.; Trump, D. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J. Clin. Oncol. 10:1066-1073; 1992.
20. Los, G.; Sminia, P.; Wondergem, J.; Mutsaers, P. H. H. A.; Haveman, J.; Bokkel Huinink ten, W. W.; Smals, O. A. G.; Gonzalez Gonzalez, D.; McVie, J. G. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur. J. Cancer 27:472-477; 1991.
21. Los, G.; Van Vugt, M. J. H.; den Engelse, L.; Pinedo H. M. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochem. Pharmacol. 46:1229-1237; 1993.
22. Los, G.; Van Vugt, M. J. H.; Pinedo, H. M. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br. J. Cancer 69:235-241; 1994.
23. Mella, O.; Eriksen, R.; Dahl, O.; Laenum, O. D. Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. Eur. J. Cancer Clin. Oncol. 23(4):365-373; 1987.
24. Oken, M. H.; Creech, R. H.; Tormey, D. L. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 5:649-655; 1982.
25. Omura, G. A. Chemotherapy for cervix cancer. Semin. Oncol. 21(1):54-62; 1994.
26. Petrovich, Z.; Langholz, B.; Gibbs, F. A.; Sapozink, M. D.; Kapp D. S.; Stewart, R. J.; Emami B.; Oleson, J. R.; Senzer, N.; Slater, J.; Astrahan, M. Regional hyperthermia for advanced tumors: A clinical study of 353 patients. Int. J. Radiat. Oncol. Biol. Phys. 16:601-607; 1989.
27. Picozzi, V. J., Jr.; Sikic, B. I.; Carlson, R. W.; Koretz, M.; Ballon, S. C. Bleomycin, mitomycin and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: A phase II study of the Northern California Oncology Group. Cancer Treat. Rep. 69(7-8):903-905; 1985.
28. Piver, M. S.; Barlow, J. J.; Lele, S. B.; Maniccia, M. Weekly cis-diamminedichloroplatinum (II) as induction chemotherapy in recurrent carcinoma of the cervix. Gynecol. Oncol. 18:313-319; 1984.
29. Planting, A. S. T.; Burg, van der M. E. L.; Boer de-Dennert, M.; Stoter, G.; Verweij, J. A phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours. Br. J. Cancer 68:789-792; 1993.
30. Potter, M. E.; Hatch, K. D.; Potter, M. Y.; Shingleton, H. M.; Baker, V. V. Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 63:1283-1286; 1989.
31. Raghavan, D.; Pearson, B.; Hunter Watt, W.; Mameghan, H.; Langdon, P.; Eisinger, D.; Wines, R. Cytotoxic chemotherapy for advanced bladder cancer: Cisplatin-containing regimens. Semin. Oncol. 18(1)(Suppl. 3):56-63; 1991.
32. Rose, P. G.; Piver, M. S.; Malfetano, J. H.; Baker, T. R.; Hempling, R. E.; Recio, F. O. A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer 71:2245-2249; 1990.
33. Sapareto, S. A.; Corry, P. M. A proposed standard data file format for hyperthermia treatments. Int. J. Radiat. Oncol. Biol. Phys. 16:613-627; 1989.
34. Smith, D. B.; Newlands, E. S.; Rustin, G. J. S.; Begert, R. H. J.; Howells, N.; McQuade, B.; Bagshawe, K. D. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338:487-490; 1991.
35. Sorbe, B.; Frankendal, D. Bleomycin-adriamycin-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent cervical carcinoma. Obstet. Gynecol. 63(2):167-170; 1984.
36. Urano, M.; Kahn, J.; Majima, H.; Gerwech, L. E. The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int. J. Hyperthermia 6:581-590; 1990.
37. Vermorken, J. B.; Kapteijn, T. S.; Hart, A. A. M.; Pinedo, H. M. Ototoxicity of cis-diamminedichloroplatinum(II): Influence of dose, schedule and mode of administration. Eur. J. Cancer Clin. Oncol. 19:53-58; 1983.
38. Wallner, K. E.; DeGregorio, M. W.; Li, G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum(II)cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res. 46:6242-6245; 1986.
39. Wheelock, J. B.; Krebs, H. B.; Goplerud, D. R.; Myers, M. Cisplatinum, doxorubicin and methotrexate treatment for recurrent cervical cancer. Obstet. Gynecol. 66(3):410-412; 1985.
40. World Health Organization: Handbook for reporting results of Cancer Treatment. WHO offset publication No. 48. Geneva, Switzerland: WHO; 1979.